Matt Sagan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Matt Sagan

Oct 23, 2024, 14:45 | Blog

Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer

Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…

Jun 7, 2024, 02:21 | Insight

Matt Sagan: Is HER2-negative breast cancer really negative?

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post on X: "Is HER2-negative breast cancer really…

Jun 4, 2024, 10:52 | Insight

Matt Sagan: Innovative approach of HER2 expression quantitative assessment using inPROBE technology

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post on X: “Innovative fiber optic–based…

Jun 4, 2024, 10:02 | Insight

Matt Sagan: President Biden and Jill Biden set two clear goals for the Biden Cancer Moonshot initiative

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by ASCO on X, adding:…

May 11, 2024, 11:23 | Insight

Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow

Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…

All: 5 Posts: 1 - 100

ASCO GI 2025 - Everything You Need To Know About Biggest Gastrointestinal cancer Symposium

Side Effects of Radiotherapy: Risks and What to Know

Isabel Rubio has been elected as the President of the European Cancer Organisation for 2026-2027

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023